Drugs / SM934
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03951259 | Jul 2019 → Oct 2023 | systemic lupus erythematosus | RenJi Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SM934 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03951259 ↗ |
| Route | Oral | “the investigating intervention is oral administration of SM934” NCT03951259 ↗ |